SCHEMBL674037

SCHEMBL674037

Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.42
GRIN2B Q13224 2/20 0.42
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.35
NOTUM Q6P988 1/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 1/20 0.34
USP1 O94782 1/20 0.33
TPH1 P17752 1/20 0.32
TPH2 Q8IWU9 1/20 0.32
MTOR P42345 1/20 0.32
LMNA P02545 1/20 0.32
CNR2 P34972 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7068410 0.96 GRIN1 (0.38) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL6088384 0.96 GRIN1 (0.38) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL6086562 0.95 MTOR (0.38) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL675171 0.92 KMT2A (0.35) GRIN1GRIN2BKMT2AMEN1TDP1
SCHEMBL7852090 0.92 GRIN1 (0.37) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL12752325 0.90 GRIN1 (0.35) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL12752283 0.89 GRIN1 (0.34) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL6087585 0.88 KMT2A (0.35) GRIN1GRIN2BKMT2AMEN1ALDH1A1
SCHEMBL7848991 0.87 MTOR (0.35) GRIN1GRIN2BKMT2AMEN1TDP1
SCHEMBL1484495 0.86 GRIN1 (0.32) GRIN1GRIN2BKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026043843-A1 TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2026-02-26 WO claimed
US-20250255968-A1 INTRAVAGINAL DEVICES FOR DRUG DELIVERY KISER PATRICK F (US) 2025-08-14 US claimed
WO-2024215771-A1 SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES SOUTHERN RESEARCH INSTITUTE (US) 2024-10-17 WO claimed
EP-4262812-A1 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS Southern Research Institute (US) 2023-10-25 EP claimed
WO-2023122212-A2 SUBSTITUTED PHENYL ETHYNYL PYRIDINE CARBOXAMIDES AS POTENT INHIBITORS OF SARS VIRUS SOUTHERN RESEARCH INSTITUTE (US) 2023-06-29 WO claimed
CN-115916175-A Novel 2-pyrimidinone analogs as potent antiviral agents against alphaviruses 南方研究院 2023-04-04 CN claimed
EP-4125845-A1 NOVEL 2-PYRIMIDONE ANALOGS AS POTENT ANTIVIRAL AGENTS AGAINST ALPHAVIRUSES Southern Research Institute (US) 2023-02-08 EP claimed
EP-4021413-A1 LIPOSOMAL TROPONOID COMPOUND FORMULATIONS United States Government as Represented by The Department of Veterans Affairs (US) 2022-07-06 EP claimed
WO-2022133323-A1 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS SOUTHERN RESEARCH INSTITUTE (US) 2022-06-23 WO claimed
US-20140209100-A1 INTRAVAGINAL DEVICES FOR DRUG DELIVERY Kiser, Patrick F. 2014-07-31 US claimed
US-20130220337-A1 DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES KISER PATRICK F (US) 2013-08-29 US claimed
EP-2605779-A2 DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES The University of Utah Research Foundation (US) 2013-06-26 EP claimed
WO-2012024605-A2 DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2012-02-23 WO claimed
US-20110045076-A1 LINEAR ORDER RELEASE POLYMER THE UNIVERSITY OF UTAH RESEARCH FOUNDATION 2011-02-24 US claimed
US-20260137765-A1 METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF INSTITUT CURIE (FR) 2026-05-21 US disclosed
WO-2026043843-A1 TETRAHYDROPYRIMIDINE (THP) IONIZABLE LIPIDS FOR EFFICIENT MRNA DELIVERY THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2026-02-26 WO disclosed
EP-4092139-B1 METHOD FOR DISCRIMINATING BETWEEN LIVE AND DEAD MICROBES IN A SAMPLE PATHOQUEST (FR) 2026-02-18 EP disclosed
WO-2009094573-A2 LINEAR ORDER RELEASE POLYMER THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 2009-07-30 WO disclosed
US-6987114-B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD (KR) 2006-01-17 US disclosed
EP-1100786-B1 ANTIVIRAL PYRIMIDINEDIONE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF SAMJIN PHARM CO LTD (KR) 2004-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137765-A1 METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF STXBP1, HBB, UPF1 GRIN1 2496/4885GRIN2B 958/4885KMT2A 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.